Skip to main content

Table 3 Baseline characteristics

From: Opioid use disorder in Germany: healthcare costs of patients in opioid maintenance treatment

 Overall (N = 955)buprenorphine (N = 350)methadone (N = 336)levomethadone (N = 269)p-value
Mean Age (SD)33.89 (8.3)33.56 (8.5)34.14 (8.2)34.01 (9.1)0.4681
Male (%)681 (71.3)258 (73.7)243 (72.3)180 (66.9)0.1575
Depression402 (42.1)156 (44.6)129 (38.4)117 (43.5)0.2247
Personality Disorder143 (15.0)39 (11.1)54 (16.1)50 (18.5)0.0285
Anxiety80 (8.4)30 (8.6)26 (7.7)24 (8.9)0.8607
Sleeping Disorder118 (12.4)47 (13.4)25 (7.4)46 (17.1)0.0011
Chronic Hepatitis C365 (38.2)126 (36.0)124 (36.9)114 (42.4)0.2292
COPD63 (6.6)20 (5.7)29 (8.6)14 (5.2)0.1699
HIV/AIDS19 (2.0)3 (0.9)11 (3.0)5 (1.9)0.0755
Cardiovascular Diseases191 (20.0)66 (18.9)67 (19.9)58 (21.56)0.706
Alcohol Use Disorder143 (14.9)49 (14.0)40 (11.9)54 (20.1)0.0162